{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:40:49Z","timestamp":1773297649775,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Since the federal ban on hemp products was lifted in December 2018, cannabidiol (CBD), a nonpsychoactive cannabinoid derived from hemp, has become increasingly popular and accessible. CBD is sold in the form of oils, tablets, and foods in locations including gas stations, caf\u00e9s, and drug stores. Despite a lack of reliable evidence, many parents praise its purported therapeutic effects on a variety of childhood ailments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Epidiolex was the first CBD-based medication to be approved by the US Food and Drug Administration in 2018 for the treatment of two rare and severe forms of epilepsy, known as Lennox\u2013Gastaut and Dravet syndrome, in patients of at least 2 years of age. Its efficacy was assessed through three randomized, double blind, and placebo-controlled trials in a sample of 516 patients with either Lennox\u2013Gastaut syndrome or Dravet syndrome. Despite this development, there are few or no large-scale, rigorous studies concerning the effects of CBD on any other pediatric conditions that parents have tried to alleviate with CBD. The purpose of this review is to explore recent literature regarding the efficacy and safety of CBD in treating various health conditions in children; the risks of consuming CBD products, and the role of pediatricians in helping parents navigate often-confusing information about CBD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Although CBD use has dramatically increased in recent years, both its potential to treat conditions and its risks have not yet been subjected to rigorous study. Pediatricians should be aware of the risks posed by poor-quality standards and labeling practices for cannabinoid products. Due to the confusing nature of the numerous sources of information about CBD, pediatricians are in a position to provide and clarify information about CBD to parents and understand the risks it poses to children.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000861","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T14:49:49Z","timestamp":1576248589000},"page":"198-205","source":"Crossref","is-referenced-by-count":14,"title":["The cannabidiol conundrum: potential benefits and risks of cannabidiol products for children"],"prefix":"10.1097","volume":"32","author":[{"given":"Lauren","family":"Singer","sequence":"first","affiliation":[{"name":"Division of Developmental and Behavioral Pediatrics, Steven and Alexandra Cohen Children's Medical Center, New Hyde Park"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Tokish","sequence":"additional","affiliation":[{"name":"Division of Developmental and Behavioral Pediatrics, Steven and Alexandra Cohen Children's Medical Center, New Hyde Park"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Developmental and Behavioral Pediatrics, Steven and Alexandra Cohen Children's Medical Center, New Hyde Park"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Campisi","sequence":"additional","affiliation":[{"name":"Division of Developmental and Behavioral Pediatrics, Steven and Alexandra Cohen Children's Medical Center, New Hyde Park"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth L.","family":"Milanaik","sequence":"additional","affiliation":[{"name":"Division of Developmental and Behavioral Pediatrics, Steven and Alexandra Cohen Children's Medical Center, New Hyde Park"},{"name":"Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","article-title":"CBD is wildly popular. Disputes over its legality are a growing source of tension","author":"Williams","year":"2019","journal-title":"N Y Times"},{"key":"R13-20230918","article-title":"\u2018Getting worse, not better\u2019: Illegal pot market booming in California despite legalization","author":"Fuller","year":"2019","journal-title":"N Y Times"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2017.11909","article-title":"Labeling accuracy of cannabidiol extracts sold online","volume":"318","author":"Bonn-Miller","year":"2017","journal-title":"JAMA"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2018.11.035","article-title":"Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia","volume":"146","author":"Stark","year":"2019","journal-title":"Neuropharmacology"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr Res"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1203\/PDR.0b013e3182276b11","article-title":"Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs","volume":"70","author":"Lafuente","year":"2011","journal-title":"Pediatr Res"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","article-title":"Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism","volume":"102","author":"Hayakawa","year":"2007","journal-title":"J Neurochem"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/brain\/aww129","article-title":"Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol","volume":"139","author":"Patel","year":"2016","journal-title":"Brain"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/epi.14629","article-title":"Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models","volume":"60","author":"Patra","year":"2019","journal-title":"Epilepsia"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","article-title":"Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy","volume":"29","author":"Porter","year":"2013","journal-title":"Epilepsy Behav"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2015.04.009","article-title":"Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox\u2013Gastaut syndrome","volume":"47","author":"Hussain","year":"2015","journal-title":"Epilepsy Behav"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40263-019-00624-4","article-title":"Pharmacokinetics and tolerability of multiple doses of pharmaceutical-grade synthetic cannabidiol in pediatric patients with treatment-resistant epilepsy","volume":"33","author":"Wheless","year":"2019","journal-title":"CNS Drugs"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1111\/epi.13815","article-title":"Quality of life in childhood epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol","volume":"58","author":"Rosenberg","year":"2017","journal-title":"Epilepsia"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","article-title":"Brief report: cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems \u2013 a retrospective feasibility study","volume":"49","author":"Aran","year":"2019","journal-title":"J Autism Dev Disord"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fphar.2018.01521","article-title":"Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities","volume":"9","author":"Barchel","year":"2019","journal-title":"Front Pharmacol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/can.2018.0053","article-title":"Treatment of Fragile X syndrome with cannabidiol: a case series study and brief review of the literature","volume":"4","author":"Tartaglia","year":"2019","journal-title":"Cannabis Cannabinoid Res"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0883073818773028","article-title":"Medical cannabis for pediatric moderate to severe complex motor disorders","volume":"33","author":"Libzon","year":"2018","journal-title":"J Child Neurol"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/pde.13545","article-title":"Self-initiated use of topical cannabidiol oil for epidermolysis bullosa","volume":"35","author":"Chelliah","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","article-title":"Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle","volume":"43","author":"Gonzalez-Cuevas","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"Br J Pharmacol"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front Pharmacol"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm J"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-005","article-title":"Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report","volume":"20","author":"Shannon","year":"2016","journal-title":"Perm J"},{"key":"R54-20230918","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.euroneuro.2017.05.005","article-title":"Cannabinoids in attention-deficit\/hyperactivity disorder: a randomised-controlled trial","volume":"27","author":"Cooper","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"R55-20230918","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000489287","article-title":"The trouble with CBD oil","volume":"1","author":"Hazekamp","year":"2018","journal-title":"Med Cannabis Cannabinoids"},{"key":"R56-20230918","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJMc0707784","article-title":"Lead poisoning due to adulterated marijuana","volume":"358","author":"Busse","year":"2008","journal-title":"N Engl J Med"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1056\/NEJMc1814130","article-title":"Adolescent vaping and nicotine use in 2017\u20132018 \u2013 U.S. national estimates","volume":"380","author":"Miech","year":"2019","journal-title":"N Engl J Med"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fphar.2016.00279","article-title":"Evaluation of two commercially available cannabidiol formulations for use in electronic cigarettes","volume":"7","author":"Peace","year":"2016","journal-title":"Front Pharmacol"},{"key":"R60-20230918","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.forsciint.2018.10.019","article-title":"The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids","volume":"294","author":"Poklis","year":"2019","journal-title":"Forensic Sci Int"},{"key":"R63-20230918","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fpsyt.2019.00063","article-title":"The endocannabinoid system and cannabidiol's promise for the treatment of substance use disorder","volume":"10","author":"Chye","year":"2019","journal-title":"Front Psychiatry"},{"key":"R64-20230918","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/npp.2017.143","article-title":"The role of the endocannabinoid system and genetic variation in adolescent brain development","volume":"43","author":"Meyer","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"R65-20230918","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopsych.2015.07.024","article-title":"The impact of exposure to cannabinoids in adolescence: insights from animal models","volume":"79","author":"Rubino","year":"2016","journal-title":"Biol Psychiatry"},{"key":"R67-20230918","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14740338.2017.1397128","article-title":"Drug\u2013drug interactions as a result of co-administering \u03949-THC and CBD with other psychotropic agents","volume":"17","author":"Rong","year":"2018","journal-title":"Expert Opin Drug Safety"},{"key":"R74-20230918","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.2196\/jmir.9370","article-title":"Health information obtained from the internet and changes in medical decision making: questionnaire development and cross-sectional survey","volume":"20","author":"Chen","year":"2018","journal-title":"J Med Internet Res"},{"key":"R75-20230918","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0009922819845163","article-title":"Paging Dr Google: the effect of online health information on trust in pediatricians\u2019 diagnoses","volume":"58","author":"Sood","year":"2019","journal-title":"Clin Pediatr"},{"key":"R76-20230918","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1007\/s10803-019-04140-8","article-title":"The internet's effect on parental trust in pediatrician diagnosis of autism and likelihood of seeking a second opinion","volume":"49","author":"Pham","year":"2019","journal-title":"J Autism Dev Disord"},{"key":"R77-20230918","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/hex.12438","article-title":"Conflicting health information: a critical research need","volume":"19","author":"Carpenter","year":"2016","journal-title":"Health Expect"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:32:56Z","timestamp":1695004376000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000861","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}